As clinicians working with individuals with disabilities, we are increasingly concerned regarding the adverse impact of cuts in funding to support individuals with disabilities and their carers.
Full article available to subscribers
As clinicians working with individuals with disabilities, we are increasingly concerned regarding the adverse impact of cuts in funding to support individuals with disabilities and their carers.
The highest proportion of funding for disability support provides services for individuals with intellectual disability (ID). Since de-institutionalisation and the National Advisory Committee’s 2003 report for the Ministry of Health, To have an ‘ordinary’ life – Kia whai orange ‘noa’,1 care for these individuals has improved significantly. However, the recent cuts threaten this for many. Here we highlight the clinical risk associated with the funding cuts for these individuals and describe what we have observed regarding the consequences of these changes. In focussing on people with ID we do not want to diminish the effects of the funding cuts for individuals with other disabilities. However, we believe that individuals with ID are among the most vulnerable in our community and are also a group of individuals for whom self-advocacy can be particularly difficult.
ID is characterised by significant intellectual impairment—an IQ of less than 70 on standardised neuropsychological testing, significant difficulties in adaptive functioning and evidence of onset prior to 18 years of age. These difficulties are lifelong. In Aotearoa New Zealand, rates of ID are higher among Māori (1.3%), with rates in Pacific peoples at 0.9% and Europeans at 0.8%.2
Individuals with ID suffer from mental illness at rates of at least two to three times that of the general population, with verbal and cognitive limitations making diagnosis particularly challenging. For example, the incidence of schizophrenia is approximately four times greater, with a similarly increased rate of bipolar disorder. Individuals with ID are significantly more likely to suffer from physical illnesses—for example, epilepsy,3 diabetes, chronic obstructive pulmonary disease and coronary heart disease2—and they develop dementia at a significantly earlier age.4 They are more likely to be sexually (a rate of 30%)4 and physically abused and to suffer other adverse life events. Neurodiversity issues are also greater among individuals with ID, with the rates of attention deficit hyperactivity disorder and autism spectrum disorder (ASD) being several times greater than in the general population.6,7 Difficulties in accessing healthcare are significant, related to difficulties in communication and to systemic and discrimination issues in the healthcare system. Life expectancy is significantly reduced by approximately 20 years.2
Until the early 2000s, many individuals with ID were housed in large institutions (e.g., Braemar, Cherry Farm, Templeton, Kimberley, Māngare, Tokanui). Care in these settings was often regimented and lacked attention to individual rights and access to the community. Polypharmacy was common in attempts to control behavioural disturbance. These institutions were progressively closed from 1996 onwards and many of the residents were re-housed in community-based homes. Currently, these homes usually have two to six residents, supported by staff up to 24 hours per day. The level of staffing varies according to the needs of the residents. Day services and vocational activities are provided to facilitate activities, education and supported employment outside their home. These services are often provided by not-for-profit, non-government organisations. The majority of individuals with ID are cared for by family at home. This situation can be stressful for families, and at times the situation can break down rapidly. Flexible “individualised” funding was intended to allow families to utilise a range of strategies to maximise the potential of the individual and to allow them to remain in their family home.
Given high rates of mental health difficulties, individuals with ID frequently require specialist mental health input. In contrast to most other developed countries, in Aotearoa New Zealand there is minimal access to services that specialise in treating the comorbidity of ID and mental health difficulties. The only comprehensive specialist service is in Canterbury. Generally, if individuals with ID require hospital in-patient care, they are admitted to general adult psychiatric wards, where there is usually no specific expertise in their care, the environment is often inappropriate and individuals are vulnerable.
In many cases problematic behaviour can and should be managed by the judicious application of positive behaviour support, involving consistent positive reinforcement for desired behaviour and management of the environment to minimise distress. Specialist advice and assessment is provided by behaviour support services nationwide. The waiting time for this service is generally between 1 year and 18 months.
Currently 50,000 clients access funding from Disability Support Services (DSS) (a 43% growth in 5 years from 2019).8 In that 5-year span, the numbers of individuals with ID accessing DSS support increased by 2,500 (to a total of approximately 19,000) and those with ASD by 9,600 (total 18,000). The greatest increase in costs has been in residential care (increased by NZ$406 million) and in flexible funding arrangements (increased by NZ$376 million).
The Independent Review Disability Support Services notes that “Almost $1bn is now spent on residential care facilities each year, a significant increase from $700m in 2015/16.”9 This represents a 43% increase on the background of an increase in consumer price index of approximately 30%10 between 2015 and 2024, a rate of rent increase above the rate of inflation, pay equity settlements (still ongoing), increased pay rates for “sleepover staff” and a 43% increase in clients (between 2019 and 2024).
Overall, we believe that several important improvements have been made in the care of individuals with ID in residential and other settings. Increasingly, dedicated services have recognised the very complex needs of individuals with ID, and have adapted services to respond to individual needs. This has often led to smaller houses with fewer residents, sensory adaptations, a focus on staff continuity and targeted improvement of staff ratios.
DSS (Ministry of Social Development ([MSD]) is responsible for contracting and funding for individuals with a long-term intellectual, physical or sensory disability, including autism, that arises before the age of 65. In 2021, a decision was made to set up Whaikaha – Ministry of Disabled People, which was launched on 1 July 2022, with responsibility for administering DSS funding. This function was transferred from the Ministry of Health. In March 2024, the Government announced a “temporary pause” that narrowed the scope of what carers could purchase to support individuals with disabilities.11 Examples of services that can no longer be “purchased” with individualised funding are therapies such as “speech language therapy, psychologist involvement in behaviour support; and occupational therapy.” These are considered “examples where other agencies may have funding responsibilities.”11 However, these services are not available within a realistic time frame with funding from any other agency.
In May 2024, a review of DSS was commissioned and the Phase One Report was published on 28 June 24.9 On 15 August 2024, the Government announced that Whaikaha would be restructured as a policy and advisory department, that DSS functions would be taken over by MSD and that there would be no financial uplift for the care and support of individuals with disabilities. Recommendation 2 was to “Freeze current levels of funding for residential facility-based care for 2024/25 pending commissioning and completion of a detailed and urgent review of the contract and pricing models”9— the latter is currently underway.
The Phase One Report was produced within 6 weeks of the appointment of a Chair, and noted that because of the time frame “Engagement with the disability community was not possible during this phase of the review.”9 No clinical staff were interviewed. In the section regarding “clinical risks”, of 10 paragraphs only one addresses clinical risks; paragraph 148 notes “There is a risk that the quality of care being provided to disabled individuals may erode during a period of funding constraint. We consider that the monitoring proposed in Recommendation 4 will be an important part of the mitigation of this risk; but we acknowledge that it may take time to establish a responsive monitoring function. In the meantime, internal processes for complaints, concerns and ongoing stakeholder management must recognise this risk and provide transparency to executives on how risks are being managed.”9 Recommendation 4 was to “establish an effective function within the Ministry to monitor the assessment and allocation performance of NASCs (Needs Assessment and Service Co-ordination and EGL (Enabling Good Lives) demonstration sites.”9
Effectively, what has been implemented is a cut in funding, involving a freeze in new residential placements and cuts to aspects of flexible funding for those individuals living at home. These funding cuts have significant implications, which are already impacting on the care of individuals with ID, as we have observed in our clinical practice:
We have observed significant adverse consequences of the current disability funding cuts and believe that these impacts will worsen over time. We suggest that there is no justification to “freeze” residential funding while reviewing the funding system and that doing so is causing unnecessary, severe harm to those with ID and their families and carers. The harm caused will not be short term. Already, the reconfiguration of services is taking place, returning individuals with ID to a situation of non-personalised care, accompanied by reduced community involvement and chemical restraint.
The loss of individualised services and skilled staff will take many years to reverse and will be costly. The trauma of these changes and the accompanying worsening of physical and mental health for individuals with ID and their families and carers will not be reversible. Hospital beds will be blocked, resulting in increased costs and potential harm for all individuals with mental health difficulties requiring in-patient admission.
These funding cuts are largely based on a report that was produced in 6 weeks, without clinical or community engagement, and which essentially had minimal consideration of the effects, other than supposed financial benefits. We urge the Government to reconsider.
During 2024, significant changes were made to funding available for the support of individuals with intellectual disability. These included a “freeze” on funding for residential care and a restriction of what flexible funding can be used for. This article examines the serious adverse effects of these changes, which we have observed in our clinical practice with this vulnerable group of people.
Richard J Porter: Distinguished Professor, Department of Psychological Medicine, University of Otago, Christchurch, Aotearoa New Zealand; Consultant Psychiatrist, Psychiatric Services for Adults with Intellectual Disability, Te Whatu Ora – Health New Zealand Waitaha Canterbury, Aotearoa New Zealand.
Henrietta Trip: Senior Lecturer, Department of Postgraduate Nursing, University of Otago, Christchurch, Aotearoa New Zealand.
Chris Daffue: Consultant Clinical Psychologist, Psychiatric Services for Adults with Intellectual Disability, Te Whatu Ora – Health New Zealand Waitaha Canterbury, Aotearoa New Zealand.
Dr Julie Fitzjohn: Consultant Psychiatrist, Psychiatric Services for Adults with Intellectual Disability, Te Whatu Ora – Health New Zealand Waitaha Canterbury, Aotearoa New Zealand.
Dr Peri Renison: Consultant Psychiatrist, Psychiatric Services for Adults with Intellectual Disability, Te Whatu Ora – Health New Zealand Waitaha Canterbury, Aotearoa New Zealand.
Richard J Porter: Department of Psychological Medicine, University of Otago, PO Box 4345, Christchurch 8140, Aotearoa New Zealand.
Richard J Porter uses software for research into cognitive remediation, provided at no cost by SBT-pro.
Henrietta Trip is Co-Chair of the Canterbury Disability Providers Network and Chair of the National Disability Nurses Branch, Te Ao Māramatanga – New Zealand Colleges of Mental Health Nurses.
Peri Renison is a Psychiatrist Member of the Mental Health Review Tribunal.
1) The National Advisory Committee on Health and Disability. To have an ‘ordinary’ life – Kia whai oranga ‘noa’: A report to the Minister of Health and the Minister for Disability Issues from the National Advisory Committee on Health and Disability [Internet]. 2003 [cited 2025 Jan 16]. Available from: https://www.abuseincare.org.nz/assets/Evidence-library/Part-1/National-Advisory-Committee-on-Health-and-Disability-To-Have-an-Ordinary-Life-Kia-Whai-Oranga-Noa-September-2003.pdf
2) Beltran-Castillon L, McLeod K. From Data to Dignity: Health and Wellbeing Indicators for New Zealanders with Intellectual Disability – Mai i te Raraunga ki te Rangatiratanga o te Noho: Ngā Tūtohu Hauora, Toiora Hoki mō te Hunga Whai Kaha o Aotearoa [Internet]. IHC New Zealand, Kōtātā Insight; 2023 [cited 2025 Jan 16]. Available from: https://assets-global.website-files.com/628455c1cd53af649dec6493/6584cc68cbd28550e09d0397_Full_IDI%20report_final_web.pdf
3) Robertson J, Hatton C, Emerson E, Baines S. Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure. 2015 Jul;29:46-62. doi: 10.1016/j.seizure.2015.03.016.
4) Cooper SA, McLean G, Guthrie B, et al. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract. 2015 Aug 27;16:110. doi: 10.1186/s12875-015-0329-3.
5) Tomsa R, Gutu S, Cojocaru D, et al. Prevalence of Sexual Abuse in Adults with Intellectual Disability: Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Feb 18;18(4):1980. doi: 10.3390/ijerph18041980.
6) Tonnsen BL, Boan AD, Bradley CC, et al. Prevalence of Autism Spectrum Disorders Among Children With Intellectual Disability. Am J Intellect Dev Disabil. 2016 Nov;121(6):487-500. doi: 10.1352/1944-7558-121.6.487.
7) Sawhney I, Perera B, Bassett P, et al. Attention-deficit hyperactivity disorder in people with intellectual disability: statistical approach to developing a bespoke screening tool. BJPsych Open. 2021 Oct 4;7(6):e187. doi: 10.1192/bjo.2021.1023.
8) Whaikaha – Ministry of Disabled People. Independent Review of Disability Support Services: Phase One Report [Internet]. 2024 Jun 28 [cited 2025 Jan 16]. Available from: https://www.disabilitysupport.govt.nz/assets/Uploads/Independent-review/05_AUGUST-CABINET-Paper-Appendix-1-Independent-DSS-Review-redactions-applied-FINAL.pdf
9) Beehive. Factsheet – Independent Review of Disability Support Services [Internet]. [cited 2025 Jan 16]. Available from: https://www.beehive.govt.nz/sites/default/files/2024-08/Disability%20Support%20Services%20Review%20Factsheet.pdf
10) Reserve Bank of New Zealand – Te Pūtea Matua. Inflation calculator [Internet]. [cited 2025 Jan 16]. Available from:
https://www.rbnz.govt.nz/monetary-policy/about-monetary-policy/inflation-calculator
11) Whaikaha – Ministry of Disabled People. Guidance for the sector on changes to the Purchase Rules [Internet]. 2024 Apr 24 [cited 2025 Jan 16]. Available from: https://www.disabilitysupport.govt.nz/assets/Guidance-for-the-Sector-24-April-2024.pdf
12) Trip H, Whitehead L, Crowe M, et al. Aging With Intellectual Disabilities in Families: Navigating Ever-Changing Seas-A Theoretical Model. Qual Health Res. 2019 Sep;29(11):1595-1610. doi: 10.1177/1049732319845344.
Disability funding cuts in New Zealand are having devastating effects on individuals with intellectual disabilities, leading to loss of care, increased hospitalisations, and a return to outdated, harmful practices. Urgent action is needed to prevent further harm.
In this video, Professor Richard Porter, Head of the Department of Psychological Medicine at the University of Otago, Christchurch, discusses the editorial alongside his collaborators. As a Consultant Psychiatrist specialising in adult intellectual disability care, he advocates for the very community he has dedicated his career to supporting
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz